Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News OpGen Inc OPGN

Healthcare Biotechnology
OpGen, Inc. is a precision medicine company that uses molecular diagnostics and informatics to combat infectious diseases. The Company distributes molecular microbiology solutions that help guide clinicians with more information about life threatening infections to improve patient outcomes and decrease the spread of infections caused by multidrug-resistant microorganisms (MDROs). The Company's... see more

Recent & Breaking News (OTCPK:OPGN)

OpGen Announces Completion of the Intermountain Healthcare Retrospective MDRO Health Outcome Study

GlobeNewswire August 8, 2016

OpGen, Inc. Announces Timing for Second Quarter Financial Results and Conference Call

GlobeNewswire August 2, 2016

The Market In 5 Minutes: Jam-Packed Day Of Earnings And Economic Data

Benzinga.com  July 21, 2016

Benzinga's M&A Chatter for Wednesday July 20, 2016

Benzinga.com  July 20, 2016

15 Biggest Mid-Day Gainers For Wednesday

Benzinga.com  July 20, 2016

OpGen Highlights Strong Performance of Acuitas® Resistome Test at ASM Microbe 2016

GlobeNewswire June 20, 2016

OpGen to Present at the 6th Annual LD Micro Invitational Conference

Accesswire June 2, 2016